Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Bioanalytical Systems, Inc.    BASI

BIOANALYTICAL SYSTEMS, INC.

(BASI)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

BIOANALYTICAL SYSTEMS INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
09/18/2020 | 06:02pm EDT

Item 2.02. Results of Operations and Financial Condition.

On August 14, 2020, Bioanalytical Systems, Inc. issued a press release announcing results for the three and nine months of fiscal 2020 ended June 30, 2020. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.




 (a) Not applicable.




 (b) Not applicable.




 (c) Not applicable.




 (d) Exhibits



99.1 Bioanalytical Systems, Inc. press release, issued August 14, 2020.

© Edgar Online, source Glimpses


share with twitter share with LinkedIn share with facebook
All news about BIOANALYTICAL SYSTEMS, INC.
10/20BIOANALYTICAL : Andrew N. Alexander, DVM, Ph.D., MBA, DABT, Joins Inotiv as Vice..
AQ
10/20Andrew N. Alexander, DVM, Ph.D., MBA, DABT, Joins Inotiv as Vice President, P..
GL
09/18BIOANALYTICAL SYSTEMS INC : Results of Operations and Financial Condition, Finan..
AQ
09/16BIOANALYTICAL SYSTEMS INC : Regulation FD Disclosure (form 8-K)
AQ
09/09BIOANALYTICAL : BASi to Participate in H.C. Wainright Investment Conference
AQ
09/09BASi to Participate in H.C. Wainright Investment Conference
GL
08/14BIOANALYTICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
08/14BASi Releases Earnings for Third Quarter of Fiscal 2020
GL
08/11BIOANALYTICAL : I.M. (Gina) Grossi, Ph.D., Joins Inotiv as Vice President of Tox..
AQ
07/15MERCK : to Invest EUR18 Million in Swiss Laboratory
DJ
More news
Financials (USD)
Sales 2019 43,6 M - -
Net income 2019 -0,79 M - -
Net Debt 2019 16,0 M - -
P/E ratio 2019 -44,9x
Yield 2019 -
Capitalization 54,8 M 54,8 M -
EV / Sales 2018 0,96x
EV / Sales 2019 1,23x
Nbr of Employees 317
Free-Float 65,4%
Chart BIOANALYTICAL SYSTEMS, INC.
Duration : Period :
Bioanalytical Systems, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOANALYTICAL SYSTEMS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Managers
NameTitle
Robert Leasure President, Chief Executive Officer & Director
Gregory C. Davis Chairman
Beth A. Taylor Chief Financial Officer & Vice President-Finance
Richard Allen Johnson Independent Director
Wendy Perrow Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BIOANALYTICAL SYSTEMS, INC.5.86%58
LONZA GROUP AG62.80%47 152
SEAGEN INC.72.54%34 263
IQVIA HOLDINGS INC.8.39%32 108
CELLTRION, INC.31.49%28 160
MODERNA, INC.260.58%27 830